Hjem › Ulcerøs kolitt › South Carolina › Greenville
Kliniske studier for Ulcerøs kolitt i Greenville, SC
5 studier for Ulcerøs kolitt søker deltakere på steder i og rundt Greenville (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
RekruttererFase 2
- Gastroenterology Associates - Patewood /ID# 283870, Greenville
A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis
RekruttererFase 3
- Patewood Medical Campus /ID# 272477, Greenville
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
RekruttererFase 3
- Gastroenterology Associates - Patewood, Greenville
LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
RekruttererFase 2
- Gastroenterology Associates, P.A. of Greenville, Greenville
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
RekruttererFase 2
- Mirador Therapeutics Selected Site, Greenville
Ulcerøs kolitt-studier i andre byer
- New York City, NY23 studier
- Orlando, FL22 studier
- Miami, FL21 studier
- Houston, TX17 studier
- San Antonio, TX16 studier
- Tyler, TX15 studier
- Tacoma, WA15 studier
- Chicago, IL15 studier
- San Diego, CA15 studier
- Colorado Springs, CO14 studier
- St. Louis, MO13 studier
- Los Angeles, CA13 studier
Andre studier i Greenville
- Ikke-småcellet lungekreft15 studier
- Brystkreft12 studier
- Akut myelogen leukemi10 studier
- Kreft (alle typer)9 studier
- Fedme9 studier
- Lungekreft9 studier
- Overvekt8 studier
- Prostatakreft7 studier
- Kolorektal kreft7 studier
- Mavekreft6 studier
- Perifer arteriell sykdom5 studier
- Burkitts lymfom5 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.